Variant report

Variant	nsv432971
Chromosome Location	chr6:162073330-162447251
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:47)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:47 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162135808..162138276-chr6:162142475..162145172,2	K562	blood:
2	chr6:162115124..162116676-chr6:162119287..162121862,2	K562	blood:
3	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:
4	chr6:162111336..162114011-chr6:162137192..162139483,2	K562	blood:
5	chr6:162080897..162083173-chr6:162084992..162086582,2	K562	blood:
6	chr6:162212614..162214396-chr6:162214709..162217609,2	MCF-7	breast:
7	chr6:162207547..162209957-chr6:162210445..162213994,3	K562	blood:
8	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
9	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
10	chr6:162211723..162213448-chr6:162215614..162217575,2	K562	blood:
11	chr6:162111336..162114011-chr6:162137192..162139483,2	K562	blood:
12	chr6:162075282..162077598-chr6:162078551..162080758,2	K562	blood:
13	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:
14	chr6:162039551..162040468-chr6:162115665..162116674,7	MCF-7	breast:
15	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
16	chr6:162347118..162349182-chr6:162351860..162355211,3	K562	blood:
17	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
18	chr20:46012429..46013123-chr6:162169752..162170322,2	MCF-7	breast:
19	chr6:162216587..162218691-chr6:162225101..162227602,2	K562	blood:
20	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
21	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
22	chr6:161813445..161815530-chr6:162115453..162117705,2	MCF-7	breast:
23	chr6:162075282..162077598-chr6:162078551..162080758,2	K562	blood:
24	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
25	chr6:162207547..162209957-chr6:162210445..162213994,3	K562	blood:
26	chr6:162080897..162083173-chr6:162084992..162086582,2	K562	blood:
27	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
28	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
29	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
30	chr6:162135808..162138276-chr6:162142475..162145172,2	K562	blood:
31	chr6:162115124..162116676-chr6:162119287..162121862,2	K562	blood:
32	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
33	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
34	chr6:162216587..162218691-chr6:162225101..162227602,2	K562	blood:
35	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
36	chr6:162211723..162213448-chr6:162215614..162217575,2	K562	blood:
37	chr6:162212614..162214396-chr6:162214709..162217609,2	MCF-7	breast:
38	chr6:162232298..162233805-chr6:162237071..162239613,2	K562	blood:
39	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
40	chr6:162313026..162315357-chr6:162317264..162319780,2	K562	blood:
41	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
42	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
43	chr6:162232298..162233805-chr6:162237071..162239613,2	K562	blood:
44	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
45	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
46	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
47	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:

No data

Extended variants
information (count: 14763 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:14763 , 50 per page) page: 1 2 3 4 5 6 7 ... 296

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs200353148	chr6:162075807-162075808	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs191575215	chr6:162075837-162075838	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs530054002	chr6:162075848-162075849	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs546895299	chr6:162075862-162075863	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs566731880	chr6:162075867-162075868	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs112346192	chr6:162075909-162075910	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs11969183	chr6:162075919-162075920	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs568904478	chr6:162075996-162075997	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs11966168	chr6:162076034-162076035	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs182664812	chr6:162076035-162076036	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs142852374	chr6:162076040-162076041	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs539810806	chr6:162076053-162076054	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs534139251	chr6:162076063-162076064	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs374908291	chr6:162076070-162076071	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs73597109	chr6:162076081-162076082	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs73597111	chr6:162076095-162076096	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs140072361	chr6:162076133-162076134	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs111891794	chr6:162076146-162076147	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs150977839	chr6:162076149-162076150	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs9458327	chr6:162076165-162076166	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs531755566	chr6:162076183-162076184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs542330057	chr6:162076207-162076208	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs562093295	chr6:162076209-162076210	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs527709131	chr6:162076214-162076215	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs9456698	chr6:162076215-162076216	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs9458328	chr6:162076228-162076229	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs532431943	chr6:162076283-162076284	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs146928689	chr6:162076284-162076285	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs373972311	chr6:162076287-162076288	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561430301	chr6:162076296-162076297	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs547899937	chr6:162076297-162076298	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs201615827	chr6:162076310-162076311	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs113411286	chr6:162076321-162076322	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs143354496	chr6:162076325-162076326	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs372017201	chr6:162076340-162076341	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs540888660	chr6:162076346-162076347	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs375054768	chr6:162076377-162076378	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs561113218	chr6:162076378-162076379	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs577515657	chr6:162076379-162076380	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs112590104	chr6:162076419-162076420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs115987320	chr6:162076423-162076424	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs576690695	chr6:162076453-162076454	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs542413790	chr6:162076463-162076464	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs562179297	chr6:162076472-162076473	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs117170258	chr6:162076497-162076498	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs11756024	chr6:162076539-162076540	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs77166092	chr6:162076546-162076547	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs76143337	chr6:162076647-162076648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs17576146	chr6:162076656-162076657	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs142804159	chr6:162076668-162076669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Bipolar disorder	19114987	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:1136 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162075800-162076000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr6:162075800-162076600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr6:162076200-162077400	Enhancers	Pancreas	Pancrea
4	chr6:162076600-162078200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr6:162077400-162078400	Enhancers	Fetal Kidney	kidney
6	chr6:162078200-162079000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr6:162078400-162079400	Weak transcription	Fetal Kidney	kidney
8	chr6:162079000-162080000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr6:162079000-162080200	Enhancers	Cortex derived primary cultured neurospheres	brain
10	chr6:162079200-162079600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr6:162079400-162080000	Enhancers	Fetal Kidney	kidney
12	chr6:162080000-162080600	Weak transcription	Fetal Kidney	kidney
13	chr6:162080000-162080800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr6:162080600-162081200	Enhancers	Fetal Kidney	kidney
15	chr6:162081200-162081800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr6:162093600-162094400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr6:162094000-162094200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr6:162094200-162094400	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr6:162094200-162094400	Enhancers	Psoas Muscle	Psoas
20	chr6:162094400-162097000	Weak transcription	Psoas Muscle	Psoas
21	chr6:162094400-162103200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr6:162096600-162098600	Enhancers	Brain Germinal Matrix	brain
23	chr6:162097000-162098600	Enhancers	Fetal Brain Female	brain
24	chr6:162097000-162098600	Enhancers	Psoas Muscle	Psoas
25	chr6:162097400-162097800	Enhancers	Fetal Brain Male	brain
26	chr6:162097400-162098200	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr6:162097600-162098200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr6:162098400-162098800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr6:162098600-162099800	Weak transcription	Brain Germinal Matrix	brain
30	chr6:162098800-162118000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr6:162099800-162100000	Enhancers	Brain Germinal Matrix	brain
32	chr6:162100000-162100200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
33	chr6:162100000-162103600	Weak transcription	Brain Germinal Matrix	brain
34	chr6:162100200-162100400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr6:162100400-162102600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr6:162102600-162104200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr6:162102600-162104400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr6:162103000-162104200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr6:162103200-162103400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr6:162103800-162104200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr6:162103800-162104800	Enhancers	Pancreas	Pancrea
42	chr6:162104000-162104600	Enhancers	Brain Germinal Matrix	brain
43	chr6:162104200-162104400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr6:162104400-162104800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr6:162104800-162107800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr6:162104800-162109800	Weak transcription	Pancreas	Pancrea
47	chr6:162107800-162108000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr6:162109600-162110200	Enhancers	Brain Anterior Caudate	brain
49	chr6:162109800-162110000	Enhancers	Pancreas	Pancrea
50	chr6:162115600-162116200	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links